Clinical Trials Directory

Trials / Completed

CompletedNCT05287620

Objective, Passive Assessment of LRRK2 Carriers

Status
Completed
Phase
Study type
Observational
Enrollment
10 (actual)
Sponsor
University of Rochester · Academic / Other
Sex
All
Age
50 Years
Healthy volunteers
Not accepted

Summary

The goal of this project is to identify objective, sensitive, and convenient measures for assessing early signs of Parkinson's disease in an at-risk population at home. We will do so by using a wireless sensor and analyzing the radio signals that bounce off patients' bodies, while patients go about their normal life without needing to wear sensors, answer questionnaires, or actively perform any tests.

Conditions

Interventions

TypeNameDescription
DEVICEEmerald deviceThe Emerald device is a wireless sensor that can track the motion, breathing, and sleep of participants without touching or requiring any interaction with the participants, allowing them to go about their normal lives. The Emerald device operates by transmitting and receiving low power radio signals that reflect off of the participant and return back to the device. The power of these signals is 1,000 times lower than what a typical Wi-Fi device transmits. The ability of the device to monitor gait, breathing, sleep, and other metrics has been validated and documented. Studies of the Emerald device in individuals with Parkinson's disease, Alzheimer's disease, and rare diseases have demonstrated the feasibility of monitoring at home and the ability to characterize gait, breathing, and sleep in these populations specifically. In this study, the Emerald device will be used to characterize the mobility, breathing and sleep of the participant.

Timeline

Start date
2022-04-27
Primary completion
2024-05-07
Completion
2024-05-07
First posted
2022-03-18
Last updated
2024-06-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05287620. Inclusion in this directory is not an endorsement.